2004
Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?
Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction 2004, 99: 349-360. PMID: 14982548, PMCID: PMC3709247, DOI: 10.1111/j.1360-0443.2003.00642.x.Peer-Reviewed Original ResearchConceptsStandard treatmentUrinalysis resultsNegative urinalysis resultsCM conditionCommunity-based treatment centersPositive urinalysis resultsCommunity-based settingsContingency management interventionSevere patientsNegative urine samplesTreatment periodCM interventionPatientsTreatment centersMore abstinenceDrug useCocaine useTreatment assignmentBeneficial effectsUrine samplesCocaine usersContingency managementTreatmentInterventionGoal-related activities
2002
Contingency Management to Enhance Naltrexone Treatment of Opioid Dependence: A Randomized Clinical Trial of Reinforcement Magnitude
Carroll KM, Sinha R, Nich C, Babuscio T, Rounsaville BJ. Contingency Management to Enhance Naltrexone Treatment of Opioid Dependence: A Randomized Clinical Trial of Reinforcement Magnitude. Experimental And Clinical Psychopharmacology 2002, 10: 54-63. PMID: 11866252, DOI: 10.1037/1064-1297.10.1.54.Peer-Reviewed Original ResearchConceptsNaltrexone treatmentContingency managementOpioid-dependent individualsSignificant reductionReinforcement magnitudeOpioid useAvailable pharmacotherapiesNaltrexone maintenanceOpioid dependenceClinical trialsCM groupBehavioral therapyNaltrexoneTreatmentCM conditionRelative benefitsParticipantsPharmacotherapyTherapyTrialsWeeks